Azacitidine (Vidaza ® ) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015).
Alba Rubio-San-SimónNatasha K A van EijkelenburgRaoull HoogendijkHenrik HasleCharlotte M NiemeyerMichael N DworzakMarco ZeccaMarta Lopez-YurdaJulie M JanssenAlwin D R HuitemaMarry M van den Heuvel-EibrinkEric J LailleHarm van TinterenChristian M ZwaanPublished in: Paediatric drugs (2023)
EudraCT 2010-022235-10.